Provided By GlobeNewswire
Last update: Jun 26, 2025
WEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of a registration statement on Form S-4 with the Securities and Exchange Commission ("SEC") related to the Company's previously announced and proposed definitive merger agreement (the "Merger") with Z Squared Inc. (“Z Squared”).
Read more at globenewswire.comNASDAQ:COEP (7/22/2025, 8:00:00 PM)
10.91
+0.21 (+1.96%)
Find more stocks in the Stock Screener